Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 30, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Cytovance Biologics Selected for GMP Manufacture of AM0010
Tuesday, July 01, 2014
Provides drug product for Phase I trials.

AMRI Completes OsoBio Acquisition
Tuesday, July 01, 2014
Oso Biopharmaceuticals is recognized as a premier contract manufacturer of highly complex injectable drug products.

Aesica Collaborates with QAD to Meet CFDA’s Shortened Serialization Deadline
Saturday, June 28, 2014
The new system was implemented within three months.

EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates
Saturday, June 28, 2014
Collaboration and license agreement allows Merck Serono to expand its oncology drug portfolio.

Initiation of a Phase IIa Clinical Study for Lynovex® in Cystic Fibrosis
Thursday, June 26, 2014
Results from the trial are expected to be announced H2 2014.

Major Cystic Fibrosis Breakthrough
Thursday, June 26, 2014
Combination of ivacaftor with lumicaftor improves lung function and reduces patients hospitalizations.

Almac’s AADx Gene Expression Marker Attracts Significant Commercial Interest from Pharma
Thursday, June 26, 2014
Evaluation in colorectal, breast and lung cancer to follow.

Companion Diagnostics Benefit from Fewer Regulatory Barriers in Europe
Thursday, June 26, 2014
Future revisions to in-vitro diagnostics laws will offset the launch of new tests, in a market expected to soar to $1,295.1 million in 2018.

Endo to Acquire DAVA Pharmaceuticals
Thursday, June 26, 2014
The acquisition enhances Endo's commercialization and development platform and is expected to be immediately accretive to company's 2014 adjusted earnings per share.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 3113
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv